New oral pill aims to clear psoriasis in major trial
Disease control
Recruiting now
This phase 3 study tests whether the experimental drug WD-890 can safely improve skin clearance in adults with moderate to severe plaque psoriasis. Participants are randomly assigned to receive either WD-890 or a placebo tablet daily for up to 52 weeks. The main goals are to see …
Phase: PHASE3 • Sponsor: Zhejiang Wenda Pharma Technology LTD. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC